» Articles » PMID: 3418853

Low-density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction

Overview
Journal JAMA
Specialty General Medicine
Date 1988 Oct 7
PMID 3418853
Citations 252
Authors
Affiliations
Soon will be listed here.
Abstract

The association of low-density lipoprotein (LDL) subclass patterns with coronary heart disease was investigated in a case-control study of nonfatal myocardial infarction. Subclasses of LDL were analyzed by gradient gel electrophoresis of plasma samples from 109 cases and 121 controls. The LDL subclass pattern characterized by a preponderance of small, dense LDL particles was significantly associated with a threefold increased risk of myocardial infarction, independent of age, sex, and relative weight. Plasma levels of high-density lipoprotein cholesterol were decreased, and levels of triglyceride, very low-density lipoproteins, and intermediate-density lipoproteins were increased in subjects with this LDL subclass pattern. Multivariate logistic regression analyses showed that both high-density lipoprotein cholesterol and triglyceride levels contributed to the risk associated with the small, dense LDL subclass pattern. Thus, the metabolic trait responsible for this LDL subclass pattern results in a set of interrelated lipoprotein changes that lead to increased risk of coronary heart disease.

Citing Articles

Clinical significance of small dense low-density lipoprotein cholesterol measurement in type 2 diabetes.

Hirano T J Diabetes Investig. 2025; 16(3):370-383.

PMID: 39778086 PMC: 11871407. DOI: 10.1111/jdi.14398.


Bone turnover: the role of lipoproteins in a population-based study.

Winckel T, Friedrich N, Zylla S, Fenzlaff M, Schopfel J, Gauss K Lipids Health Dis. 2024; 23(1):302.

PMID: 39300501 PMC: 11411916. DOI: 10.1186/s12944-024-02290-y.


The relationship between cardiometabolic index and pulmonary function among U.S. adults: insights from the National Health and Nutrition Examination Survey (2007-2012).

Mo C, Pu J, Zheng Y, Li Y Lipids Health Dis. 2024; 23(1):246.

PMID: 39127689 PMC: 11316304. DOI: 10.1186/s12944-024-02235-5.


Interaction Between Primary Hyperlipidemias and Type 2 Diabetes: Therapeutic Implications.

Zubiran R, Cruz-Bautista I, Aguilar-Salinas C Diabetes Ther. 2024; 15(9):1979-2000.

PMID: 39080218 PMC: 11330433. DOI: 10.1007/s13300-024-01626-2.


A Comparison of Rosuvastatin Monotherapy and Rosuvastatin Plus Ezetimibe Combination Therapy in Patients With Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials.

Dadzie S, Tabowei G, Kaur M, Ahmed S, Thakur A, Khreis K Cureus. 2024; 16(6):e61526.

PMID: 38957250 PMC: 11218846. DOI: 10.7759/cureus.61526.